Challenges implementing technology transfer as a viable pathway for equitable vaccine production and access: A case study of the mRNA vaccine hub in South Africa.
IF 2.1 3区 医学Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Omowamiwa Kolawole, Caroline Ncube, Jeremy de Beer
{"title":"Challenges implementing technology transfer as a viable pathway for equitable vaccine production and access: A case study of the mRNA vaccine hub in South Africa.","authors":"Omowamiwa Kolawole, Caroline Ncube, Jeremy de Beer","doi":"10.1080/17441692.2025.2504698","DOIUrl":null,"url":null,"abstract":"<p><p>In the face of the COVID-19 pandemic, there have been renewed calls for more equitable vaccine access. These calls have in turn resulted in interventions to increase vaccine manufacturing capacity as one of the key interventions to address global vaccine access. However, skill gaps in manufacturing capacity point out the critical need for technology transfer and more open science. The World Health Organization-instituted mRNA hub in South Africa has been positioned as an initiative to facilitate technology transfer for building and leveraging vaccine manufacturing capacity in low and middle income countries. Our case study examines the activities of the mRNA vaccine hub, highlighting challenges that can stifle the long-term goals of equitable vaccine production if left unaddressed. The findings suggest that for technology transfer to be effective, there must be sufficient institutional commitment, adequate funding that is fit for purpose, clear terms and an enabling legal and socio-economic environment.</p>","PeriodicalId":12735,"journal":{"name":"Global Public Health","volume":"20 1","pages":"2504698"},"PeriodicalIF":2.1000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17441692.2025.2504698","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
In the face of the COVID-19 pandemic, there have been renewed calls for more equitable vaccine access. These calls have in turn resulted in interventions to increase vaccine manufacturing capacity as one of the key interventions to address global vaccine access. However, skill gaps in manufacturing capacity point out the critical need for technology transfer and more open science. The World Health Organization-instituted mRNA hub in South Africa has been positioned as an initiative to facilitate technology transfer for building and leveraging vaccine manufacturing capacity in low and middle income countries. Our case study examines the activities of the mRNA vaccine hub, highlighting challenges that can stifle the long-term goals of equitable vaccine production if left unaddressed. The findings suggest that for technology transfer to be effective, there must be sufficient institutional commitment, adequate funding that is fit for purpose, clear terms and an enabling legal and socio-economic environment.
期刊介绍:
Global Public Health is an essential peer-reviewed journal that energetically engages with key public health issues that have come to the fore in the global environment — mounting inequalities between rich and poor; the globalization of trade; new patterns of travel and migration; epidemics of newly-emerging and re-emerging infectious diseases; the HIV/AIDS pandemic; the increase in chronic illnesses; escalating pressure on public health infrastructures around the world; and the growing range and scale of conflict situations, terrorist threats, environmental pressures, natural and human-made disasters.